Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
arm was "very sore"; This is a spontaneous report and received from Consumer or other non HCPs. A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm was "very sore"". Additional information: The reporter stated that the arm of the patient was "very sore" after she received her COVID-19 vaccine. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. Follow-up (01Feb2025): This is a spontaneous follow-up report received from a Consumer or other non HCP. Updated information included: New reporter and patient Information. Follow-up (12Feb2025): This is a spontaneous follow-up report received from a Consumer or other non HCP. Updated information included: Primary Reporter Qualification.